SIENTRA INC (SIEN)
US82621J2042 - Common Stock
We assign a fundamental rating of 1 out of 10 to SIEN. SIEN was compared to 193 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SIEN have multiple concerns. SIEN is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SIEN has reported negative net income.
In the past year SIEN has reported a negative cash flow from operations.
SIEN had negative earnings in each of the past 5 years.
SIEN had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
SIEN has a worse Return On Assets (-42.26%) than 64.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.26% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-42.93%
ROA(5y)-46.03%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 42.12%, SIEN is doing worse than 62.94% of the companies in the same industry.
SIEN's Gross Margin has declined in the last couple of years.
SIEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.12% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.81%
GM growth 5Y-5.59%
2. Health
2.1 Basic Checks
SIEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SIEN has been increased compared to 1 year ago.
The number of shares outstanding for SIEN has been increased compared to 5 years ago.
The debt/assets ratio for SIEN is higher compared to a year ago.
2.2 Solvency
SIEN has an Altman-Z score of -8.45. This is a bad value and indicates that SIEN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -8.45, SIEN is not doing good in the industry: 74.62% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.45 |
ROIC/WACCN/A
WACC5.68%
2.3 Liquidity
SIEN has a Current Ratio of 0.57. This is a bad value and indicates that SIEN is not financially healthy enough and could expect problems in meeting its short term obligations.
SIEN's Current ratio of 0.57 is on the low side compared to the rest of the industry. SIEN is outperformed by 95.94% of its industry peers.
A Quick Ratio of 0.31 indicates that SIEN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.31, SIEN is doing worse than 97.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.57 | ||
| Quick Ratio | 0.31 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 48.90% over the past year.
SIEN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.46%.
SIEN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.90% yearly.
EPS 1Y (TTM)48.9%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q45.42%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y2.66%
Revenue growth 5Y19.9%
Revenue growth Q2Q-13.42%
3.2 Future
Based on estimates for the next years, SIEN will show a very strong growth in Earnings Per Share. The EPS will grow by 23.71% on average per year.
Based on estimates for the next years, SIEN will show a small growth in Revenue. The Revenue will grow by 5.11% on average per year.
EPS Next Y61.42%
EPS Next 2Y34.93%
EPS Next 3Y23.71%
EPS Next 5YN/A
Revenue Next Year-3.12%
Revenue Next 2Y1.1%
Revenue Next 3Y5.11%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
SIEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SIEN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as SIEN's earnings are expected to grow with 23.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.93%
EPS Next 3Y23.71%
5. Dividend
5.1 Amount
SIEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SIENTRA INC
NASDAQ:SIEN (2/21/2024, 7:07:31 PM)
After market: 0.1798 +0.01 (+3.33%)0.174
-0.04 (-18.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.08M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.26% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 42.12% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.57 | ||
| Quick Ratio | 0.31 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)48.9%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y61.42%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.46%
Revenue growth 3Y2.66%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y